XML 104 R89.htm IDEA: XBRL DOCUMENT v3.8.0.1
Equity-Based Compensation Plans - Additional Information (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 12 Months Ended 37 Months Ended
Dec. 31, 2017
Mar. 31, 2017
Dec. 31, 2016
Dec. 31, 2017
Dec. 31, 2016
Dec. 31, 2015
Jan. 31, 2012
Mar. 31, 2018
Dec. 31, 2014
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares 657,319   527,054 657,319 527,054 277,693     150,580
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price $ 52.84   $ 51.83 $ 52.84 $ 51.83 $ 64.47     $ 66.84
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price $ 66.85 $ 66.85   $ 66.85          
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value $ 0   $ 7 $ 0 $ 7 $ 0     $ 0
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross       158,484 280,191 142,542      
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price       $ 56.45 $ 38.86 $ 61.93      
Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested Options Forfeited, Number of Shares       (22,306) (30,830) (15,429)      
Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price       $ 50.74 $ 47.79 $ 64.12      
Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period       (5,913)          
Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price       $ 66.97          
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Remaining Contractual Term       6 years          
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term       7 years          
Stock Plan, effective date       Dec. 16, 2008          
Share Based Compensation Arrangement By Share Based Payment Award Effective Grant Date 2008 Plan Amended and Restated       Feb. 28, 2017          
Stock Plan, shares authorized 6,200,000     6,200,000          
Shares Available For Grant 3,600,000     3,600,000          
Distributed of Previously Deferred Shares 1,775                
Cash paid for minimum tax withholdings       $ 1,127 $ 933 $ 4,152      
Share based compensation expense       $ (6,453) (7,605) (8,630)      
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number 131,947 137,860   131,947          
Options, Vested and Expected to be Exercised, Outstanding, Weighted Average Exercise Price $ 61.95     $ 61.95          
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term       7 years 5 months          
Equity Option [Member]                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                  
Unrecognized compensation costs $ 3,100     $ 3,100          
Unrecognized compensation costs, expected weighted-average period to be recognized (in years)       1 year 5 months          
Performance Shares [Member]                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                  
Share based compensation awards vesting period       3 years          
Unrecognized compensation costs $ 2,300     $ 2,300          
Unrecognized compensation costs, expected weighted-average period to be recognized (in years)       1 year 2 months          
Vested Shares Settled Without Payment 41,538     0          
Settlement and distribution of shares issued (in shares)     45,953            
Shares issued (in shares)   27,878              
Share based compensation expense       $ (2,283) $ (3,311) $ (4,408)      
Performance Shares [Member] | Minimum                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                  
Percentage of amount subject to performance share award of number of shares actually issued     0.00%   0.00%        
Performance Shares [Member] | Maximum                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                  
Percentage of amount subject to performance share award of number of shares actually issued     200.00%   200.00%        
Employee Stock Option [Member]                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value       $ 18.82 $ 14.42 $ 20.82      
Share based compensation expense       $ (2,552) $ (2,913) $ (2,106)      
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value       $ 7,700          
Employee Stock Option [Member] | Minimum                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                  
Share based compensation awards vesting period       1 year          
Employee Stock Option [Member] | Maximum                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                  
Share based compensation awards vesting period       3 years          
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period       10 years          
Restricted Stock Units (RSUs)                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value       $ 1,100          
Unrecognized compensation costs $ 2,800     $ 2,800          
Unrecognized compensation costs, expected weighted-average period to be recognized (in years)       1 year 9 months          
Settlement and distribution of shares issued (in shares) 20,940   19,196 25,940 45,143        
Shares issued (in shares)       17,834 30,093        
Cash paid for minimum tax withholdings       $ 1,100 $ 900        
Balance of Shares Vested and Deferred     33,663   33,663        
Share based compensation expense       $ (1,618) $ (1,381) (2,116)      
Restricted Stock Units (RSUs) | Minimum                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                  
Share based compensation awards vesting period       1 year          
Restricted Stock Units (RSUs) | Maximum                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                  
Share based compensation awards vesting period       3 years          
Cellu Tissue Holdings Inc                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                  
Stock Plan, shares authorized 700,000     700,000          
Director                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                  
Share based compensation awards vesting period       1 year     3 years    
Share based compensation expense       $ 2,800 (4,800) $ (4,100)      
Deferred compensation share-based arrangements, liability, classified, noncurrent $ (3,600)   $ (7,900) (3,600) (7,900)        
Deferred Compensation Share-based Arrangements, Liability, Current $ (2,400)   $ (3,200) $ (2,400) $ (3,200)        
Scenario, Forecast [Member]                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number               124,617